Christian Gloeckner

This inventor holds 12 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignee: Illumina Corporation. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Gloeckner. Retrieved from https://idiyas.com/inventor/christian-gloeckner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 249(Granted Patents)

Company Filing History:

12 out of 1,216

Illumina Corporation

patents

Years Active: 2017-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371690 - Methods and compositions using one-sided transposition (2025-07-29),

2. 12351868 - Enzyme-linked nucleotides (2025-07-08),

3. 12180468 - Transposase compositions for reduction of insertion bias (2024-12-31),

4. 11965158 - Methods and compositions using one-sided transposition (2024-04-23),

5. 10968448 - Methods and compositions using one-sided transposition (2021-04-06),

6. 10815478 - Method of sequential tagmentation with transposase compositions for reduction of insertion bias (2020-10-27),

7. 10767221 - Enzyme-linked nucleotides (2020-09-08),

8. 10577603 - Methods and compositions using one-sided transposition (2020-03-03),

9. 10544403 - Modified transposases for improved insertion sequence bias and increased DNA input tolerance (2020-01-28),

10. 10385323 - Modified transposases for improved insertion sequence bias and increased DNA input tolerance (2019-08-20),

11. 10035992 - Modified transposases for improved insertion sequence bias and increased DNA input tolerance (2018-07-31),

12. 9790476 - Modified transposases for improved insertion sequence bias and increased DNA input tolerance (2017-10-17),

Title: Christian Gloeckner: Innovator in Nucleic Acid Research

Introduction: Christian Gloeckner, based in Bonn, Germany, is a prominent inventor recognized for his contributions to the field of nucleic acid research. With a portfolio of 12 patents, he has made significant advancements that enhance next-generation sequencing technologies. His work focuses on methods and compositions that push the boundaries of understanding genetic sequences.

Latest Patents: Among his latest patents, Gloeckner has developed innovative methods and compositions using one-sided transposition. These embodiments address the preparation of a template library from a target nucleic acid, facilitating sequencing and capturing contiguity information—a vital aspect of genomic analysis. Additionally, he has introduced enzyme-linked nucleotides that allow for improved distinguishing of nucleotide sequences across different nucleic acid molecules. These advancements promise to enhance the accuracy and efficiency of sequencing technologies.

Career Highlights: Christian Gloeckner is currently working with Illumina Corporation, a leader in genomic sequencing and bioinformatics. His role at the company allows him to collaborate with other brilliant minds in the field, driving innovations that transform genetic research.

Collaborations: Gloeckner frequently collaborates with notable colleagues such as Amirali Kia and Molly Min He. Together, they explore new methodologies and solutions in nucleic acid sequencing, striving to advance the capabilities available to researchers in genetics and molecular biology.

Conclusion: With his extensive patent portfolio and significant contributions to nucleic acid research, Christian Gloeckner exemplifies the spirit of innovation in the genomic sciences. His work at Illumina Corporation and collaborations with talented professionals solidify his status as a key figure in the evolution of sequencing technologies.

Profile summary based on public USPTO records.